Tim Mayleben
Director/Board Member at MARINUS PHARMACEUTICALS, INC.
Net worth: 24 815 $ as of 2024-04-29
Profile
Tim M.
Mayleben is the founder of Esperance BioVentures LLC, which was founded in 1998.
He is currently the Lead Independent Director at Marinus Pharmaceuticals, Inc. since 2008 and a Director at Wolverine Venture Fund.
Previously, he served as the President, Chief Executive Officer & Director of Esperion Therapeutics, Inc. from 2010 to 2021.
He also held positions as the Non-Executive Chairman of Kaleo, Inc., Director of Aksys Ltd., Director of Vericel Corp., Director of Rubicon Genomics, Inc., President, Chief Operating Officer & Director of NightHawk Radiology Holdings, Inc., Director of Solulink, Inc., Director of Lycera Corp., and Independent Director of Loxo Oncology, Inc. from 2015 to 2019.
Additionally, he is currently an Independent Director at Landos Biopharma, Inc. from 2021 to 2024.
He previously served as the Chief Operating & Financial Officer of Esperion Therapeutics, Inc. from 1998 to 2004.
He also held positions at Applied Intelligent Systems, Inc. and Transom Technologies, Inc. Furthermore, he is an Advisory Board Member of Michigan Ross Zell Lurie Institute.
Mr. Mayleben received his undergraduate degree from Stephen M.
Ross School of Business in 1984 and his MBA from Kellogg School of Management in 1997.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-31 | 17,475 ( 0.03% ) | 24 815 $ | 2024-04-29 | |
LANDOS BIOPHARMA, INC.
-.--% | 2024-05-22 | 0 ( -.--% ) | - $ | 2024-04-29 |
Tim Mayleben active positions
| Companies | Position | Start |
|---|---|---|
| MARINUS PHARMACEUTICALS, INC. | Director/Board Member | 2008-11-30 |
Wolverine Venture Fund
 Wolverine Venture Fund Investment ManagersFinance Wolverine Venture Fund, an evergreen fund invests in companies located in the US. The fund targets companies that are affiliated with the University of Michigan and operating in the fields of biomedicine, healthcare IT, advanced materials, and other emerging technologies. It provides financing for seed and early-stage capital requirements with an investment size ranging from $50,000 to $100,000 and also makes co-investment rights. | Director/Board Member | - |
Esperance BioVentures LLC
 Esperance BioVentures LLC Investment ManagersFinance Founded in 1998 by Roger Newton and Timothy Mayleben, Esperance BioVentures LLC is a venture capital firm located in Ann Arbor, Michigan | Founder | 2010-10-10 |
Former positions of Tim Mayleben
| Companies | Position | End |
|---|---|---|
| LANDOS BIOPHARMA, INC. | Chief Executive Officer | 2022-06-20 |
| ESPERION THERAPEUTICS, INC. | Chief Executive Officer | 2021-05-16 |
| LOXO ONCOLOGY INC | Director/Board Member | 2019-02-14 |
Lycera Corp.
 Lycera Corp. Pharmaceuticals: MajorHealth Technology Lycera Corp. develops novel oral medicines for treating autoimmune diseases and cancer. It specializes in immune metabolism, cell signaling and immune cell differentiation. The firm designed gut-directed ATPase modulator, designated LYC-30937, for the treatment of inflammatory bowel disease, and oral RORgamma agonists for diverse applications in immune-oncology. The company was founded in 2006 by Anthony William Opipari, Jr., and Gary D. Glick and is headquartered in Ann Arbor, MI. | Director/Board Member | 2017-03-12 |
| VERICEL CORPORATION | Chief Executive Officer | 2013-05-01 |
Training of Tim Mayleben
| Kellogg School of Management | Masters Business Admin |
| Stephen M. Ross School of Business | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 5 |
|---|---|
| ESPERION THERAPEUTICS, INC. | Health Technology |
| VERICEL CORPORATION | Health Technology |
| AKSYS LTD. | Finance |
| MARINUS PHARMACEUTICALS, INC. | Health Technology |
| LANDOS BIOPHARMA, INC. | Health Technology |
| Private companies | 11 |
|---|---|
Rubicon Genomics, Inc.
 Rubicon Genomics, Inc. Medical SpecialtiesHealth Technology Rubicon Genomics, Inc. engages in the provision of pre-analytical amplification technologies. The firm specializes in enzymology, nucleic acid chemistry, sample processing and manufacturing. The company was founded by Dr. John Langmore and Vladimir Makarov in 2000 and is headquartered in Ann Arbor, MI. | Health Technology |
NightHawk Radiology Holdings, Inc.
 NightHawk Radiology Holdings, Inc. Medical/Nursing ServicesHealth Services NightHawk Radiology Holdings, Inc. provides radiology solutions to radiology groups and hospitals throughout the United States. The company's team of independent contractor and hospital-privileged physicians provides professional services 24 hours per day, seven days a week, for approximately 26 percent of all United States hospitals. In addition to these professional services, the company also provides its customers with cardiac 3D reconstructions, radiology clinical workflow technology and business services. It sells its services primarily through the direct sales force comprised of telesales and field sales personnel | Health Services |
Esperance BioVentures LLC
Esperance BioVentures LLC Investment ManagersFinance Founded in 1998 by Roger Newton and Timothy Mayleben, Esperance BioVentures LLC is a venture capital firm located in Ann Arbor, Michigan | Finance |
Michigan Ross Zell Lurie Institute / Venture Capital/
 Michigan Ross Zell Lurie Institute / Venture Capital/ Investment ManagersFinance Michigan Ross Zell Lurie Institute / Venture Capital/ (Zell Lurie Institute) is a venture capital subsidiary of Zell Lurie Institute for Entrepreneurial Studies Studies founded in 1997 by Samuel Zell, Ann Lurie and Robert H. Lurie. The firm is headquartered in Ann Arbor, Michigan. | Finance |
Transom Technologies, Inc.
 Transom Technologies, Inc. Information Technology ServicesTechnology Services Transom Technologies, Inc. develops 3-D simulation and modeling software. The company is based in Ann Arbor, MI. Transom Technologies was acquired by Engineering Animation, Inc. on September 23, 1998 for $13 million. | Technology Services |
Kaleo, Inc.
 Kaleo, Inc. Pharmaceuticals: MajorHealth Technology Kaleo, Inc. develops drug/device combination products. Its products empower patients to gain freedom from their medical condition. The firm's capabilities include drug development, device development, regulatory and clinical, manufacturing, commercialization and data generation. The company was founded by Eric S. Edwards and Evan T. Edwards in 2005 and is headquartered in Richmond, VA. | Health Technology |
Lycera Corp.
Lycera Corp. Pharmaceuticals: MajorHealth Technology Lycera Corp. develops novel oral medicines for treating autoimmune diseases and cancer. It specializes in immune metabolism, cell signaling and immune cell differentiation. The firm designed gut-directed ATPase modulator, designated LYC-30937, for the treatment of inflammatory bowel disease, and oral RORgamma agonists for diverse applications in immune-oncology. The company was founded in 2006 by Anthony William Opipari, Jr., and Gary D. Glick and is headquartered in Ann Arbor, MI. | Health Technology |
Applied Intelligent Systems, Inc.
 Applied Intelligent Systems, Inc. Medical SpecialtiesHealth Technology Part of MKS Instruments, Inc., Applied Intelligent Systems, Inc. is a company that manufactures machine vision computers. The company is based in Ann Arbor, MI. Applied Intelligent Systems was acquired by Electro Scientific Industries, Inc., part of MKS Instruments, Inc. from February 01, 2019 on December 02, 1997 for $60.55 million. | Health Technology |
Solulink, Inc.
 Solulink, Inc. Medical SpecialtiesHealth Technology Solulink, Inc. provides bioconjugation products and services. It offers magnetic beads and agarose, antibody labeling kits, flow cytometry reagents, antibody-oligo kits, biotin, digoxigenin and horseradish peroxidase labeling products, crosslinking products, peptide and oligo linking, and accessories. The company was founded by David Schwartz in 2003 and is headquartered in San Diego, CA. | Health Technology |
Loxo Oncology, Inc.
 Loxo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Loxo Oncology, Inc. is a biopharmaceutical company, which engages in the development of small molecule therapeutics for the treatment of cancer. It focuses on genetic alterations, targeted therapies, and genetic testing. The company was founded by Joshua H. Bilenker in May 2013 and is headquartered in Stamford, CT. | Health Technology |
Wolverine Venture Fund
Wolverine Venture Fund Investment ManagersFinance Wolverine Venture Fund, an evergreen fund invests in companies located in the US. The fund targets companies that are affiliated with the University of Michigan and operating in the fields of biomedicine, healthcare IT, advanced materials, and other emerging technologies. It provides financing for seed and early-stage capital requirements with an investment size ranging from $50,000 to $100,000 and also makes co-investment rights. | Finance |
- Stock Market
- Insiders
- Tim Mayleben
